
|Videos|October 29, 2013
The Role of Regorafenib in Colorectal Cancer
Author(s)S. Gail Eckhardt, MD
S. Gail Eckhardt, MD, discusses the role of regorafenib in colorectal cancer.
Advertisement
S. Gail Eckhardt, MD, professor and head of the Division of Medical Oncology at the University of Colorado Denver and Health Sciences Center, discusses the role of regorafenib in colorectal cancer.
Clinical Pearls
- Regorafenib is a great option for community physicians who do not have access to clinical trials
- The approval of regorafenib gives physicians a level of activity to improve upon but is only an incremental improvement for patients
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
3
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
4
Early Relapse Guides Use of CAR T vs Other Options in LBCL
5








































